Kanserde Beslenme
Özet
Kanser hastaları, hastalığın neden olduğu metabolik değişiklikler nedeniyle sıklıkla kilo kaybı ve yetersiz beslenme yaşarlar. Bu, vücudu zayıflatabilir, tedaviye yanıtı bozabilir ve hastanın yaşam kalitesini olumsuz etkileyebilir. Beslenme, bireylerin, özellikle kanser teşhisi konanların genel refahında çok önemli bir rol oynar. Diyet, hastalığın ilerlemesini, tedavi sonuçlarını ve yaşam kalitesini çeşitli yönleriyle etkileyebileceğinden, beslenme ve kanser arasındaki ilişki karmaşıktır. Dengeli ve kişiye özel bir diyet, tedavinin yan etkilerini yönetmeye, bağışıklık sistemini desteklemeye ve vücudun kanserin zorluklarıyla başa çıkma yeteneğini geliştirmeye yardımcı olabilir.
Referanslar
Ravasco P. Nutrition in cancer patients. J Clin Med. 2019;8(8):1–13.
Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr [Internet]. 2021;40(5):2898–913. Available from: https://doi.org/10.1016/j.clnu.2021.02.005
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol [Internet]. 2011 May;12(5):489–95. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1470204510702187
Uysal E, Akbörü MH. Kanser hastalarında görülen malnütrisyon, sarkopeni ve kaşeksi nedenleri. Turk Onkol Derg. 2020;35(1):17–21.
Mısırlıoğlu PE, Köse B. Kanserde Kaşeksi ve Beslenme. Arşiv Kaynak Tarama Derg [Internet]. 2023 Mar 31;32(1):26–32. Available from: http://dergipark.org.tr/tr/doi/10.17827/aktd.1213292
Blauwhoff-Buskermolen S, Versteeg KS, De Van Der Schueren MAE, Den Braver NR, Berkhof J, Langius JAE, et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol. 2016;34(12):1339–44.
Tsai Y Te, Lai CH, Huang TH, Hsieh CC, Huang EI, Lee YC, et al. Association of malnutrition with postoperative complication risk after curative surgery for oral cancer Observational study. Med (United States). 2020;99(52).
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr [Internet]. 2017 Feb;36(1):11–48. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0261561416301819
Mayne ST, Playdon MC, Rock CL. Diet, nutrition, and cancer: Past, present and future. Nat Rev Clin Oncol. 2016;13(8):504–15.
World Health Organization (WHO) & IA for R on C. Cancer Fact Sheets-Breast, GLOBOCAN. 2020.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M, et al. Early detection of cancer. Science (80- ). 2022;375(6586).
Pekmezci H, Başaran B. Nutritional Habits of Cancer Patients. Turkiye Klin J Nurs Sci. 2021;13(2):386–95.
Cotogni P. Enteral versus parenteral nutrition in cancer patients: Evidences and controversies. Ann Palliat Med. 2016;5(1):42–9.
Boullata JI, Carrera AL, Harvey L, Escuro AA, Hudson L, Mays A, et al. ASPEN Safe Practices for Enteral Nutrition Therapy. J Parenter Enter Nutr. 2017;41(1):15–103.
McGrath KH. Parenteral nutrition use in children with cancer. Pediatr Blood Cancer. 2019;66(12):1–8.
Hvas CL, Farrer K, Donaldson E, Blackett B, Lloyd H, Forde C, et al. Quality and safety impact on the provision of parenteral nutrition through introduction of a nutrition support team. Eur J Clin Nutr. 2014;68(12):1294–9.
Muhsiroglu O. Medical nutrition treatment in cancer patients. Gulhane Med J. 2018;59(4):79–88.
Ferreri C, Sansone A, Chatgilialoglu C, Ferreri R, Amézaga J, Burgos MC, et al. Critical Review on Fatty Acid-Based Food and Nutraceuticals as Supporting Therapy in Cancer. Int J Mol Sci. 2022;23(11).
Maino Vieytes CA, Taha HM, Burton-Obanla AA, Douglas KG, Arthur AE. Carbohydrate Nutrition and the Risk of Cancer. Curr Nutr Rep. 2019;8(3):230–9.
Hossain F, Andreana PR. Developments in carbohydrate-based cancer therapeutics. Pharmaceuticals. 2019;12(2).
Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol [Internet]. 2019;16(10):605–16. Available from: http://dx.doi.org/10.1038/s41575-019-0173-3
Lu K, Dong S, Wu X, Jin R, Chen H. Probiotics in Cancer. Front Oncol. 2021;11(March).
Sotoudegan F, Daniali M, Hassani S, Nikfar S, Abdollahi M. Reappraisal of probiotics’ safety in human. Food Chem Toxicol [Internet]. 2019;129(January):22–9. Available from: https://doi.org/10.1016/j.fct.2019.04.032
van Poppel G, van den Berg H. Vitamins and cancer. Cancer Lett [Internet]. 1997 Mar;114(1–2):195–202. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0304383597046624
Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr [Internet]. 2021;40(5):2898–913. Available from: https://doi.org/10.1016/j.clnu.2021.02.005
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol [Internet]. 2011 May;12(5):489–95. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1470204510702187
Uysal E, Akbörü MH. Kanser hastalarında görülen malnütrisyon, sarkopeni ve kaşeksi nedenleri. Turk Onkol Derg. 2020;35(1):17–21.
Mısırlıoğlu PE, Köse B. Kanserde Kaşeksi ve Beslenme. Arşiv Kaynak Tarama Derg [Internet]. 2023 Mar 31;32(1):26–32. Available from: http://dergipark.org.tr/tr/doi/10.17827/aktd.1213292
Blauwhoff-Buskermolen S, Versteeg KS, De Van Der Schueren MAE, Den Braver NR, Berkhof J, Langius JAE, et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol. 2016;34(12):1339–44.
Tsai Y Te, Lai CH, Huang TH, Hsieh CC, Huang EI, Lee YC, et al. Association of malnutrition with postoperative complication risk after curative surgery for oral cancer Observational study. Med (United States). 2020;99(52).
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr [Internet]. 2017 Feb;36(1):11–48. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0261561416301819
Mayne ST, Playdon MC, Rock CL. Diet, nutrition, and cancer: Past, present and future. Nat Rev Clin Oncol. 2016;13(8):504–15.
World Health Organization (WHO) & IA for R on C. Cancer Fact Sheets-Breast, GLOBOCAN. 2020.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M, et al. Early detection of cancer. Science (80- ). 2022;375(6586).
Pekmezci H, Başaran B. Nutritional Habits of Cancer Patients. Turkiye Klin J Nurs Sci. 2021;13(2):386–95.
Cotogni P. Enteral versus parenteral nutrition in cancer patients: Evidences and controversies. Ann Palliat Med. 2016;5(1):42–9.
Boullata JI, Carrera AL, Harvey L, Escuro AA, Hudson L, Mays A, et al. ASPEN Safe Practices for Enteral Nutrition Therapy. J Parenter Enter Nutr. 2017;41(1):15–103.
McGrath KH. Parenteral nutrition use in children with cancer. Pediatr Blood Cancer. 2019;66(12):1–8.
Hvas CL, Farrer K, Donaldson E, Blackett B, Lloyd H, Forde C, et al. Quality and safety impact on the provision of parenteral nutrition through introduction of a nutrition support team. Eur J Clin Nutr. 2014;68(12):1294–9.
Muhsiroglu O. Medical nutrition treatment in cancer patients. Gulhane Med J. 2018;59(4):79–88.
Ferreri C, Sansone A, Chatgilialoglu C, Ferreri R, Amézaga J, Burgos MC, et al. Critical Review on Fatty Acid-Based Food and Nutraceuticals as Supporting Therapy in Cancer. Int J Mol Sci. 2022;23(11).
Maino Vieytes CA, Taha HM, Burton-Obanla AA, Douglas KG, Arthur AE. Carbohydrate Nutrition and the Risk of Cancer. Curr Nutr Rep. 2019;8(3):230–9.
Hossain F, Andreana PR. Developments in carbohydrate-based cancer therapeutics. Pharmaceuticals. 2019;12(2).
Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol [Internet]. 2019;16(10):605–16. Available from: http://dx.doi.org/10.1038/s41575-019-0173-3
Lu K, Dong S, Wu X, Jin R, Chen H. Probiotics in Cancer. Front Oncol. 2021;11(March).
Sotoudegan F, Daniali M, Hassani S, Nikfar S, Abdollahi M. Reappraisal of probiotics’ safety in human. Food Chem Toxicol [Internet]. 2019;129(January):22–9. Available from: https://doi.org/10.1016/j.fct.2019.04.032
van Poppel G, van den Berg H. Vitamins and cancer. Cancer Lett [Internet]. 1997 Mar;114(1–2):195–202. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0304383597046624
Sayfalar
65-72
Gelecek
29 Eylül 2023
Telif Hakkı (c) 2023 Akademisyen Kitap Portalı
Lisans
LisansNasıl Atıf Yapılır
1.
Kaplan E, Sir Ö. Kanserde Beslenme. Içinde: Dege G, Yıldırım MS, editörler. Beslenme ve Hemşirelik [Internet]. Türkiye: Akademisyen Yayınevi Kitap DOI Portalı; 2023 [a.yer 15 Temmuz 2026]. ss. 65-72. Erişim adresi: https://omp35.books.akademisyen.net/index.php/akya/catalog/book/2738/chapter/13017
